Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.John LaMattina of Pfizer will headline March Luncheon
John LaMattina, PhD, has agreed to give his presentation “Dispelling Pharma R&D Myths” at the luncheon. Dr. LaMattina is now retired from a 30-year career with Pfizer. Before
John LaMattina, PhD, has agreed to give his presentation “Dispelling Pharma R&D Myths” at the luncheon. Dr. LaMattina is now retired from a 30-year career with Pfizer. Before
US-based biopharmaceutical company TissueGene has announced that its South Korean licensing partner Kolon Life Science has received regulatory allowance from the Korea Food and Drug Administration to initiate
In late February, I. Lanier Avant, the Majority staff director of the committee, stated a bill to reauthorise the Chemical Facility Anti- Terrorism Standards (CFATS) and add Inherently
Jim DeLisi of Fanwood Chemical testified on behalf of SOCMA and hammered the main points that the statute will not require “sweeping change” and that Congress should look
Marinus Pharmaceuticals, a specialty pharmaceutical company, has met its primary endpoint for its Phase II clinical trial investigating the safety and efficacy of ganaxolone as adjunctive therapy in
PhotoMedex, which is engaged in the development, manufacturing and marketing of medical laser products and services, has completed the acquisition of Photo Therapeutics, a developer and provider of
The 2008 performance was primarily driven by sales of BioThrax (Anthrax Vaccine Adsorbed), the company’s FDA licensed vaccine for the prevention of anthrax, offset somewhat by a lower
Pfizer and Bausch & Lomb, an eye care company, have signed a co-promotion agreement involving both companies’ prescription ophthalmic pharmaceuticals in the US. The agreement will allow both
This will allow the company to open a Phase I study evaluating the safety of GGTI-2418 during the first quarter of 2009. GGTI-2418 is a synthetic peptidomimetic inhibitor
According to Aethlon, the Hemopurifier is a medical device that assists the immune response in combating infectious disease through real-time therapeutic filtration of infectious viruses and immunosuppressive proteins